$236.49
1.720.73%
Last update: 12:57 PM
15 minutes delayed
Comments
Loading...
L3Harris Technologies
LHXNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
L3Harris Technologies (NYSE:LHX) Stock, Analyst Ratings, Price Targets, Forecasts
L3Harris Technologies Inc has a consensus price target of $238.32 based on the ratings of 24 analysts. The high is $270 issued by Susquehanna on January 30, 2023. The low is $207 issued by Goldman Sachs on September 23, 2021. The 3 most-recent analyst ratings were released by Wells Fargo, JP Morgan, and Barclays on May 7, 2024, May 1, 2024, and April 30, 2024, respectively. With an average price target of $246.67 between Wells Fargo, JP Morgan, and Barclays, there's an implied 4.30% upside for L3Harris Technologies Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
JP Morgan
Barclays
RBC Capital
Alembic Global
1calculated from analyst ratings
Analyst Ratings for L3Harris Technologies
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | Buy Now | 3.6% | Wells Fargo | Matthew Akers | $238 → $245 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | 5.71% | JP Morgan | Seth Seifman | $240 → $250 | Maintains | Overweight | Get Alert |
| 04/30/2024 | Buy Now | 3.6% | Barclays | David Strauss | $238 → $245 | Maintains | Overweight | Get Alert |
| 04/29/2024 | Buy Now | 5.71% | RBC Capital | Ken Herbert | $245 → $250 | Maintains | Outperform | Get Alert |
| 04/22/2024 | Buy Now | 0.64% | Alembic Global | Peter Skibitski | → $238 | Upgrade | Neutral → Overweight | Get Alert |
| 02/13/2024 | Buy Now | 3.6% | Citigroup | Jonathan Raviv | $238 → $245 | Maintains | Buy | Get Alert |
| 01/30/2024 | Buy Now | 0.64% | Wells Fargo | Matthew Akers | $250 → $238 | Maintains | Overweight | Get Alert |
| 01/29/2024 | Buy Now | 3.6% | RBC Capital | Ken Herbert | $235 → $245 | Maintains | Outperform | Get Alert |
| 01/29/2024 | Buy Now | -3.17% | UBS | Myles Walton | $222 → $229 | Maintains | Neutral | Get Alert |
| 01/29/2024 | Buy Now | -0.63% | Raymond James | Brian Gesuale | $220 → $235 | Maintains | Outperform | Get Alert |
| 01/11/2024 | Buy Now | 1.48% | JP Morgan | Seth Seifman | → $240 | Upgrade | Neutral → Overweight | Get Alert |
| 12/15/2023 | Buy Now | 1.48% | Deutsche Bank | Scott Deuschle | $184 → $240 | Upgrade | Hold → Buy | Get Alert |
| 12/14/2023 | Buy Now | 5.71% | Truist Securities | Michael Ciarmoli | $224 → $250 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | -6.97% | Raymond James | Brian Gesuale | $210 → $220 | Maintains | Outperform | Get Alert |
| 12/13/2023 | Buy Now | -4.86% | RBC Capital | Ken Herbert | → $225 | Reiterates | Outperform → Outperform | Get Alert |
| 12/07/2023 | Buy Now | -4.86% | RBC Capital | Ken Herbert | → $225 | Reiterates | Outperform → Outperform | Get Alert |
| 11/29/2023 | Buy Now | -5.28% | Truist Securities | Michael Ciarmoli | → $224 | Reiterates | Buy → Buy | Get Alert |
| 11/28/2023 | Buy Now | -2.74% | Wells Fargo | Matthew Akers | $211 → $230 | Maintains | Overweight | Get Alert |
| 10/31/2023 | Buy Now | -8.66% | Baird | Peter Arment | $198 → $216 | Upgrade | Neutral → Outperform | Get Alert |
| 10/30/2023 | Buy Now | -4.86% | RBC Capital | Ken Herbert | $240 → $225 | Maintains | Outperform | Get Alert |
| 10/30/2023 | Buy Now | -11.2% | Raymond James | Brian Gesuale | → $210 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/20/2023 | Buy Now | -4.01% | Truist Securities | Michael Ciarmoli | $255 → $227 | Maintains | Buy | Get Alert |
| 09/28/2023 | Buy Now | -18.81% | Deutsche Bank | Scott Deuschle | → $192 | Initiates | → Hold | Get Alert |
| 09/18/2023 | Buy Now | -11.62% | Wells Fargo | Matthew Akers | $204 → $209 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 09/11/2023 | Buy Now | -18.39% | Citigroup | Jonathan Raviv | → $193 | Reinstates | → Buy | Get Alert |
| 08/28/2023 | Buy Now | -11.2% | Bernstein | Douglas Harned | $239 → $210 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/18/2023 | Buy Now | 1.48% | RBC Capital | Ken Herbert | → $240 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2023 | Buy Now | -11.2% | B of A Securities | Ronald Epstein | $230 → $210 | Maintains | Neutral | Get Alert |
| 07/31/2023 | Buy Now | 5.71% | Jefferies | Sheila Kahyaoglu | $260 → $250 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 1.48% | RBC Capital | Ken Herbert | $250 → $240 | Maintains | Outperform | Get Alert |
| 07/28/2023 | Buy Now | -13.74% | Wells Fargo | Matthew Akers | $202 → $204 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | Buy Now | 5.71% | RBC Capital | Ken Herbert | → $250 | Reiterates | → Outperform | Get Alert |
| 05/01/2023 | Buy Now | -6.13% | Baird | Peter Arment | $241 → $222 | Maintains | Neutral | Get Alert |
| 05/01/2023 | Buy Now | -1.05% | Credit Suisse | Scott Deuschle | $240 → $234 | Maintains | Outperform | Get Alert |
| 02/01/2023 | Buy Now | -2.74% | Wells Fargo | Matthew Akers | $219 → $230 | Maintains | Equal-Weight | Get Alert |
| 01/30/2023 | Buy Now | 11.63% | Morgan Stanley | Kristine Liwag | $278 → $264 | Maintains | Overweight | Get Alert |
| 01/30/2023 | Buy Now | 7.83% | Truist Securities | Michael Ciarmoli | $264 → $255 | Maintains | Buy | Get Alert |
| 01/30/2023 | Buy Now | 14.17% | Susquehanna | Charles Minervino | $265 → $270 | Maintains | Positive | Get Alert |
| 01/20/2023 | Buy Now | 1.48% | Credit Suisse | Scott Deuschle | $244 → $240 | Maintains | Outperform | Get Alert |
| 01/12/2023 | Buy Now | 1.48% | Cowen & Co. | Gautam Khanna | $260 → $240 | Maintains | Outperform | Get Alert |
| 01/11/2023 | Buy Now | -7.4% | Wells Fargo | Kristine Liwag | $260 → $219 | Maintains | Equal-Weight | Get Alert |
| 12/19/2022 | Buy Now | 1.91% | Baird | Peter Arment | $290 → $241 | Downgrade | Outperform → Neutral | Get Alert |
| 12/15/2022 | Buy Now | 17.55% | Morgan Stanley | Kristine Liwag | $263 → $278 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/12/2022 | Buy Now | 5.71% | JP Morgan | Seth Seifman | $260 → $250 | Maintains | Neutral | Get Alert |
| 11/11/2022 | Buy Now | 5.71% | B of A Securities | Ronald Epstein | $285 → $250 | Downgrade | Buy → Neutral | Get Alert |
| 11/10/2022 | Buy Now | — | Argus Research | John Eade | — | Downgrade | Buy → Hold | Get Alert |
| 11/10/2022 | Buy Now | 11.21% | Morgan Stanley | Kristine Liwag | $276 → $263 | Maintains | Equal-Weight | Get Alert |
| 10/31/2022 | Buy Now | 22.63% | Baird | Peter Arment | $332 → $290 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | — | Raymond James | Brian Gesuale | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/12/2022 | Buy Now | 12.9% | Credit Suisse | Scott Deuschle | → $267 | Initiates | → Outperform | Get Alert |
| 10/11/2022 | Buy Now | — | Wolfe Research | Myles Walton | — | Initiates | → Peer Perform | Get Alert |
| 09/28/2022 | Buy Now | 0.64% | Wells Fargo | Matthew Akers | → $238 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/30/2022 | Buy Now | 20.51% | RBC Capital | Ken Herbert | → $285 | Initiates | → Outperform | Get Alert |
| 05/02/2022 | Buy Now | 26.01% | Susquehanna | Charles Minervino | $302 → $298 | Maintains | Positive | Get Alert |
| 04/29/2022 | Buy Now | 22.63% | Raymond James | Brian Gesuale | $243 → $290 | Maintains | Outperform | Get Alert |
| 03/07/2022 | Buy Now | 23.05% | Wells Fargo | Matthew Akers | $240 → $291 | Maintains | Overweight | Get Alert |
| 03/02/2022 | Buy Now | 16.71% | Morgan Stanley | Kristine Liwag | $230 → $276 | Maintains | Equal-Weight | Get Alert |
| 02/02/2022 | Buy Now | 2.75% | Raymond James | Brian Gesuale | $250 → $243 | Maintains | Outperform | Get Alert |
| 02/01/2022 | Buy Now | 7.83% | Susquehanna | Charles Minervino | $264 → $255 | Maintains | Positive | Get Alert |
| 02/01/2022 | Buy Now | 1.48% | Wells Fargo | Matthew Akers | $254 → $240 | Maintains | Overweight | Get Alert |
| 01/11/2022 | Buy Now | 12.48% | Wolfe Research | Michael Maugeri | → $266 | Upgrade | Peer Perform → Outperform | Get Alert |
| 01/10/2022 | Buy Now | — | Wells Fargo | Matthew Akers | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/06/2022 | Buy Now | 4.87% | Baird | Peter Arment | → $248 | Upgrade | Neutral → Outperform | Get Alert |
| 12/14/2021 | Buy Now | -0.63% | UBS | Myles Walton | — | Downgrade | Buy → Neutral | Get Alert |
| 11/04/2021 | Buy Now | -2.74% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
| 11/02/2021 | Buy Now | 2.75% | Wells Fargo | Matthew Akers | — | Maintains | Equal-Weight | Get Alert |
| 09/23/2021 | Buy Now | -12.47% | Goldman Sachs | Noah Poponak | — | Downgrade | Neutral → Sell | Get Alert |
| 09/08/2021 | Buy Now | — | Wolfe Research | Michael Maugeri | — | Initiates | → Peer Perform | Get Alert |
| 08/11/2021 | Buy Now | 0.64% | Morgan Stanley | Kristine Liwag | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/04/2021 | Buy Now | 14.17% | Susquehanna | Charles Minervino | — | Maintains | Positive | Get Alert |
| 08/04/2021 | Buy Now | 5.71% | Raymond James | Brian Gesuale | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for L3Harris Technologies (LHX) stock?
The latest price target for L3Harris Technologies (NYSE:LHX) was reported by Wells Fargo on May 7, 2024. The analyst firm set a price target for $245.00 expecting LHX to rise to within 12 months (a possible 3.60% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for L3Harris Technologies (LHX)?
The latest analyst rating for L3Harris Technologies (NYSE:LHX) was provided by Wells Fargo, and L3Harris Technologies maintained their overweight rating.
When was the last upgrade for L3Harris Technologies (LHX)?
The last upgrade for L3Harris Technologies Inc happened on April 22, 2024 when Alembic Global raised their price target to $238. Alembic Global previously had a neutral for L3Harris Technologies Inc.
When was the last downgrade for L3Harris Technologies (LHX)?
The last downgrade for L3Harris Technologies Inc happened on August 28, 2023 when Bernstein changed their price target from $239 to $210 for L3Harris Technologies Inc.
When is the next analyst rating going to be posted or updated for L3Harris Technologies (LHX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of L3Harris Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for L3Harris Technologies was filed on May 7, 2024 so you should expect the next rating to be made available sometime around May 7, 2025.
Is the Analyst Rating L3Harris Technologies (LHX) correct?
While ratings are subjective and will change, the latest L3Harris Technologies (LHX) rating was a maintained with a price target of $238.00 to $245.00. The current price L3Harris Technologies (LHX) is trading at is $236.49, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.